Although the biological activity by which Copaxone (glatiramer) exerts its effects i multiple sclerosis (MS) patients is not fully understood, it is believed it can block the induction of autoimmune encephalomyelitis as observed in recent experiments with mice. Research in animals and in vitro systems suggest that glatiramer acetate-specific suppressor…
symptoms
Recommended Posts
- Long-term study finds MS disease activity stayed low for up to 13 years
- Best lifestyle habits for MS may shift over time, study finds
- Early data from twin late-stage MS drug trials expected by year’s end
- Scientists build mathematical model to track MS relapse patterns
- Stroke drug may ease MS damage, animal studies suggest